VA-CMHC-Yale Schizophrenia Research Program
Mission
To study the pathophysiology of schizophrenia and to develop better treatments for it.
Research Portfolio
- Laboratory Studies of Psychotomimetic Drugs in Healthy Humans
- Development of stand-alone and add-on treatments for positive, negative and cognitive symptoms of schizophrenia
- Brain imaging (PET, MRI, EEG)
- Cognitive Remediation
- Genetics
Who is eligible?
- Individuals diagnosed with Schizophrenia or other psychotic disorders.
- Healthy Controls
Leadership
- Deepak Cyril D'Souza, MD, Associate Professor of Psychiatry, Clinic Chief
- Mohini Ranganathan, MD, Assistant Professor of Psychiatry, Associate Chief
Yale Faculty
D'Souza, Deepak
Associate Professor of Psychiatry
Director Schizophrenia Research Program VACHS
Director, Neurobiological Studies Unit, VACHS
Director, VA-CMHC Schizophrenia Research Clinic
Ranganathan, Mohini
Assistant Professor of Psychiatry
Sewell, R.
Associate Research Scientist in Psychiatry
Skosnik, Patrick
Associate Research Scientist in Psychiatry
Zimolo, Zoran
Assistant Professor of Psychiatry
Contact Us
For more information about the clinic and our research programs, please call Kimberlee Forselius at 203-974-7540.
Location
Clinical Neuroscience Research Unit (3rd Floor)
Connecticut Mental Health Center
34 Park Street
New Haven, CT 06519
Neurobiological Studies Unit
G9West
VA Connecticut HealthCare System
950 Campbell Avenue
West-Haven, CT 06519
Schizophrenia Research Clinic
G7West
VA Connecticut HealthCare System
950 Campbell Avenue
West-Haven, CT 06519
